125 related articles for article (PubMed ID: 7428359)
21. Serum prolactin levels in lactating women using progestasert system.
Badraoui MH; Askalani H; Mahrous I; Osman MI; Bayad MA; Ibrahim II; Abdalla MT
Popul Sci; 1981; (2):115-20. PubMed ID: 12339477
[TBL] [Abstract][Full Text] [Related]
22. Clinical performance of a levonorgestrel-releasing intracervical contraceptive device during the first year of use.
Ratsula K
Contraception; 1987 Dec; 36(6):659-66. PubMed ID: 3128429
[TBL] [Abstract][Full Text] [Related]
23. Complications of use of intrauterine devices among HIV-1-infected women.
Sinei SK; Morrison CS; Sekadde-Kigondu C; Allen M; Kokonya D
Lancet; 1998 Apr; 351(9111):1238-41. PubMed ID: 9643743
[TBL] [Abstract][Full Text] [Related]
24. A comparison of the delta copper T and the copper T 200 in Bologna, Italy.
Melega C; Biscontin S; Canedi L; Marchesini FP; Tirelli S; Bartolotti T; Flamigni C
Acta Eur Fertil; 1986; 17(1):39-41. PubMed ID: 3727892
[TBL] [Abstract][Full Text] [Related]
25. Clinical evaluation of U-coil progesterone releasing device versus inert U-coil IUD.
Serour GI; Hamza A; El Sheikha Z; Hefnawi FI
Popul Sci; 1982; (3):121-35. PubMed ID: 12266213
[TBL] [Abstract][Full Text] [Related]
26. Levonorgestrel plasma concentrations and hormone profiles after insertion and after one year of treatment with a levonorgestrel-IUD.
Nilsson CG; Lähteenmäki P; Luukkainen T
Contraception; 1980 Mar; 21(3):225-33. PubMed ID: 6771090
[TBL] [Abstract][Full Text] [Related]
27. Intrauterine steroid contraceptives.
Scholten PC; Christaens GC; Haspels AA
Wien Med Wochenschr; 1987 Nov; 137(20-21):479-83. PubMed ID: 3131966
[TBL] [Abstract][Full Text] [Related]
28. Levonorgestrel-releasing IUD as a method of contraception with therapeutic properties.
Luukkainen T; Toivonen J
Contraception; 1995 Nov; 52(5):269-76. PubMed ID: 8585882
[TBL] [Abstract][Full Text] [Related]
29. Selecting patients and inserting the Progestasert.
Soderstrom RM
Am J Gynecol Health; 1989; 3(3-S):17-8. PubMed ID: 12284993
[TBL] [Abstract][Full Text] [Related]
30. Prolonged intrauterine contraception: a seven-year randomized study of the levonorgestrel 20 mcg/day (LNg 20) and the Copper T380 Ag IUDS.
Sivin I; Stern J; Coutinho E; Mattos CE; el Mahgoub S; Diaz S; Pavez M; Alvarez F; Brache V; Thevenin F
Contraception; 1991 Nov; 44(5):473-80. PubMed ID: 1797462
[TBL] [Abstract][Full Text] [Related]
31. Serum cortisol level in lactating women using Progestasert system.
Askalani H; Badraoui MH; Mahrous T; Osman MI; Bayad MA; Ibrahim II; Abdalla MI
Popul Sci; 1981; (2):109-14. PubMed ID: 12339476
[TBL] [Abstract][Full Text] [Related]
32. [The acceptability of current contraceptive methods to adolescents].
Sotnikova EI; Dubnitskaia LV; Perminova SG
Akush Ginekol (Mosk); 1993; (3):26-30. PubMed ID: 8048682
[TBL] [Abstract][Full Text] [Related]
33. Long-term use of intrauterine devices.
Novak MK; Andolsek L; Balogh SA; Waszak CS
IPPF Med Bull; 1988 Feb; 22(1):1-3. PubMed ID: 12281431
[TBL] [Abstract][Full Text] [Related]
34. Effect of prior pregnancy and combined oral contraceptives on baseline menstrual blood loss and bleeding response to intrauterine devices.
Andrade AT; de Souza JP; Rowe PJ; Shaw ST
Contraception; 1979 Jul; 20(1):19-26. PubMed ID: 477314
[TBL] [Abstract][Full Text] [Related]
35. Progesterone/progestogen releasing intrauterine systems versus either placebo or any other medication for heavy menstrual bleeding.
Lethaby AE; Cooke I; Rees M
Cochrane Database Syst Rev; 2000; (2):CD002126. PubMed ID: 10796865
[TBL] [Abstract][Full Text] [Related]
36. Comparison of T Cu 200 and Progestasert IUDs.
Lavin P; Bravo C; Waszak C
Contracept Deliv Syst; 1983 Apr; 4(2):143-7. PubMed ID: 12338635
[TBL] [Abstract][Full Text] [Related]
37. Immediate post-termination insertion of Copper 7 and Dalkon Shield intrauterine contraceptive devices.
Newton J; Elias J; Johnson A
J Obstet Gynaecol Br Commonw; 1974 May; 81(5):389-92. PubMed ID: 4832320
[TBL] [Abstract][Full Text] [Related]
38. Long-term suppression of hypermenorrhea by progesterone intrauterine contraceptive devices.
Parmer J
Am J Obstet Gynecol; 1984 Jul; 149(5):578-9. PubMed ID: 6742031
[TBL] [Abstract][Full Text] [Related]
39. A review of the use of intrauterine devices in nulliparous women.
Graham S; Simcock BW
Contraception; 1982 Oct; 26(4):323-46. PubMed ID: 6759026
[TBL] [Abstract][Full Text] [Related]
40. [Copper-7 intrauterine device (Gravigard). Report of experience].
Jürgensen O; Stenzel I; Wirth A; Sina D; Taubert HD
Fortschr Med; 1976 Mar; 94(9):515-21. PubMed ID: 964914
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
